BIOCOM
A stranger
Transition2BIO: Support the TRANSITION towards the BIOeconomy for a more sustainable future through communication e...
BIOCOM AG
participó en un
H2020:
H2020-FNR-2020
Transition2BIO will built upon the most relevant communication and education EU funded projects and initiatives to contribute to the impleme...
2020-08-18 - 2022-12-31 | financed
2020-08-18 - 2022-12-31 | financed
COMBINE: Collaboration for Prevention and Treatment of MDR Bacterial Infections
BIOCOM AG
participó en un
H2020:
H2020-JTI-IMI2-2018-15-two-stage
The loss of antibiotic effectiveness due to increasing antimicrobial resistance (AMR) is a serious threat to global public health. The IMI2...
2019-11-27 - 2025-10-31 | financed
2019-11-27 - 2025-10-31 | financed
ETHNA System: Ethics Governance System for RRI in Higher Education Funding and Research Centres
BIOCOM AG
participó en un
H2020:
H2020-SwafS-2018-2020
The Objective of Ethna System is to develop and implement an Ethics Governance System for grounding good practices in RRI (ETHNA System) in...
2019-11-14 - 2023-06-30 | financed
2019-11-14 - 2023-06-30 | financed
BE-Rural: Bio based strategies and roadmaps for enhanced rural and regional development in the EU
BIOCOM AG
participó en un
H2020:
H2020-RUR-2018-2020
The overall goal of BE-Rural is to realise the potential of regional and local bio-based economies by supporting relevant actors in the part...
2019-04-16 - 2022-07-31 | financed
2019-04-16 - 2022-07-31 | financed
BioSTEP: Promoting stakeholder engagement and public awareness for a participative governance of the European...
BIOCOM AG
participó en un
H2020:
H2020-ISIB-2014-2015
The bioeconomy holds potential solutions to important challenges of the future. The social, economic and environmental impacts associated wi...
2015-02-16 - 2018-02-28 | financed
2015-02-16 - 2018-02-28 | financed
OPTIBIOCAT: Optimized esterase biocatalysts for cost effective industrial production
BIOCOM AG
participó en un
FP7:
OPTIBIOCAT is a 48 months project aimed at developing biocatalysts based on feruloyl esterases (FAEs) and glucuronoyl esterases (GEs) for pr...
financed
financed
PHARMASEA: Increasing Value and Flow in the Marine Biodiscovery Pipeline
BIOCOM AG
participó en un
FP7:
The PharmaSea project focuses on obstacles in marine biodiscovery research, development and commercialization and brings together a broad in...
financed
financed
* No data from the current company are not available.